Clinical, Transcriptional and Haplotype Characterization of Recurrent MYBPC3 Splice-Site Variants c.1458-1G>A and c.3331-1G>A Associated with Hypertrophic Cardiomyopathy in Northern Italy
Genes · 28.07.2026 · 17 (8) · 882
DOI: 10.3390/genes17080882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 28.07.2026. Verfasst von Carlotta Pia Cristalli und 29 weiteren Autor:innen. Beteiligte Einrichtung: SSD Biologia e Medicina Molecolare, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Carrier Proteins, RNA Splice Sites. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Italian Ministry of Health.
Abstract (Originalsprache)
Background
Founder mutations in MYBPC3 may contribute substantially to the genetic burden of hypertrophic cardiomyopathy (HCM) and provide important insights into genotype–phenotype correlations and population-specific disease mechanisms. In this study, we investigated two recurrent canonical splice-site variants, MYBPC3 c.1458-1G>A and c.3331-1G>A, identified in patients with HCM from the Emilia-Romagna region of Northern Italy.
Methods
Ninety-one unrelated patients with HCM carrying either MYBPC3c.1458-1G>A or c.3331-1G>A were analyzed. Haplotype reconstruction was performed to assess a possible founder effect and estimate the approximate age of the shared ancestral allele. Functional characterization was carried out by RNA sequencing of myocardial tissue to evaluate the impact of the variants on splicing. Clinical and phenotypic data were compared with those of carriers of other truncating MYBPC3 variants or pathogenic variants in other sarcomeric genes.
Results
Both variants, classified as pathogenic according to ACMG criteria, shared a conserved variant-specific core haplotype. Founder age was estimated at approximately 10.5 generations (~262 years), consistent with a regional founder effect. RNA sequencing demonstrated aberrant splicing for both variants, resulting in premature termination codons and presumably subsequent nonsense-mediated mRNA decay. Clinically, carriers showed delayed disease onset, with a mean onset in the fifth decade of life, and a comparatively milder phenotype, including a lower incidence of sudden cardiac death, than patients carrying other truncating MYBPC3 variants or pathogenic variants in other sarcomeric genes. Both variants exhibited partial penetrance (approximately 63–67%) and age-dependent variable expressivity. Conclusions:MYBPC3 c.1458-1G>A and c.3331-1G>A represent novel founder alleles associated with HCM in Northern Italy. Identification of these locally prevalent variants improves molecular diagnosis, family screening, and supports the development of variant-targeted therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SSD Biologia e Medicina Molecolare, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), 1105 Amsterdam, The Netherlands.
- Unit of Medical Genetics, Department of Medical Sciences and Department of Mother and Child, University Hospital S. Anna Ferrara, 44121 Ferrara, Italy.
- Medical Genetics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- Unit of Cardiology, Bentivoglio Hospital, 40010 Bentivoglio, Italy.
ORCID-Profile: Carlotta Pia Cristalli, Maria Alessandra Schiavo, Miryam Rosa Stella Foti, Sara Calabrese, Federica Isidori, Alice Margutti, Federico Barocelli, Elia De Maria, Alessandro Fucili, Biagio Sassone, Laura Pezzoli, Maria Iascone, Maria Piane, Claudio Graziano, Rita Selvatici, Alessandra Ferlini, Daniela Turchetti, Francesca Gualandi, Cesare Rossi
Förderung
- Ministry of Health
- Italian Ministry of Health
Zitieren
APA
Cristalli, C. P., Schiavo, M. A., Foti, M. R. S., Calabrese, S., Isidori, F., Margutti, A., Laricchiuta, P., Governatori, G., Lai, F., Uliana, V., Barocelli, F., De Maria, E., Fucili, A., Sassone, B., Parmeggiani, G., Perugini, E., Lucca, C., Cappuccini, F., Pezzoli, L., …, & Rossi, C. (2026). Clinical, Transcriptional and Haplotype Characterization of Recurrent MYBPC3 Splice-Site Variants c.1458-1G>A and c.3331-1G>A Associated with Hypertrophic Cardiomyopathy in Northern Italy. Genes, 17(8), 882. https://doi.org/10.3390/genes17080882
Vancouver
Cristalli CP, Schiavo MA, Foti MRS, Calabrese S, Isidori F, Margutti A, et al. Clinical, Transcriptional and Haplotype Characterization of Recurrent MYBPC3 Splice-Site Variants c.1458-1G>A and c.3331-1G>A Associated with Hypertrophic Cardiomyopathy in Northern Italy. Genes. 2026;17(8):882. doi:10.3390/genes17080882
BibTeX
@article{Cristalli2026,
author = {Cristalli, Carlotta Pia and Schiavo, Maria Alessandra and Foti, Miryam Rosa Stella and Calabrese, Sara and Isidori, Federica and Margutti, Alice and Laricchiuta, Pierluigi and Governatori, Giulia and Lai, Francesco and Uliana, Vera and Barocelli, Federico and De Maria, Elia and Fucili, Alessandro and Sassone, Biagio and Parmeggiani, Giulia and Perugini, Enrica and Lucca, Camilla and Cappuccini, Francesca and Pezzoli, Laura and Iascone, Maria and Piane, Maria and Vitale, Giovanni and Graziano, Claudio and Selvatici, Rita and Ferlini, Alessandra and Graziosi, Maddalena and Biagini, Elena and Turchetti, Daniela and Gualandi, Francesca and Rossi, Cesare},
title = {Clinical, Transcriptional and Haplotype Characterization of Recurrent MYBPC3 Splice-Site Variants c.1458-1G>A and c.3331-1G>A Associated with Hypertrophic Cardiomyopathy in Northern Italy},
journal = {Genes},
year = {2026},
volume = {17},
number = {8},
pages = {882},
doi = {10.3390/genes17080882}
}
EUVIMED